Abstract
In breast cancer, as in most other malignant human tumors, the most ominous aspect of the oncogenic process is the local invasion and subsequent metastasis of the primary tumor. The single most important prognostic factor in patients with breast cancer is the presence of neoplastic cells in the axillary lymph nodes [1]. If these nodes are positive for cancer cells, there is the potential for the dissemination of tumor cells to the lungs, adrenals, liver, bone, and brain. The growth of metastatic foci at these distant sites is the most common cause of death for patients with breast cancer. Although our understanding of the pathogenesis of metastasis formation has increased, progress has been slowed by the profound complexity of the metastatic cascade. One successful strategy for dealing with this complexity has been to separate the metastatic process into a series of steps and to define specific genes or gene products that are activated at each step [2]. This has led to the emergence of several basic themes, which have allowed identification of new strategies for the diagnosis and therapy of breast cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Price, J.E. (1990) The biology of metastatic breast cancer. Cancer 66:1313–1320.
Liotta, L.A. (1986) Tumor invasion and metastasis—Role of the extracellular matrix. Cancer Res. 46:1–7.
Muschel, R.J., Williams, J.E., Lowy, D.R., Liotta, L.A. (1985) Harvey ras induction of metastatic potential depends on oncogene activation and the type of recipient cell. Am. J. Pathol. 121:1–8.
Garbesa, S., Pozzatti, R., Muschel, R.J., Saffiotti, U., Bollin, M., Goldfarb, R.H., Khoury, G., Liotta, L.A. (1987) Secretion of type IV collagenolytic protease and the metastatic phenotype: Induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-Ela. Cancer Res. 47:1523–1528.
Muschel, R.J., Liotta, L.A. (1988) Role of oncogenes in metastasis. Carcinogenesis 9:705–710.
Barsky, S.H., Siegal, G.P., Jannotta, F., Liotta, L.A. (1988) Loss of basement membrane components by invasive tumors but not by their benign counterparts. Lab. Invest. 49:140–147.
Gottesman, M. (1990) The role of proteases in cancer. Semin. Cancer Biol. 1:97–100.
Lola, P.K., Graham, C.H. (1990) Mechanisms of trophoblast invasiveness and their control: The role of proteases and protease inhibitors. Cancer Metastasis Rev. 9:369–380.
Alexander, C.M., Werb, Z. (1991) Extracellular matrix degradation. In: Hay, E.D., ed., Cell Biology of Extracellular Matrix, 2nd ed. Plenum Press, New York.
Banda, M.J., Herron, G.S., Murphy, G., Werb, Z., Dwyer, K.S. (1988) Proteinase induction by endothelial cells during wound repair. Prog. Clin. Biol. Res. 266:117–130.
Moscatelli, D., Rifkin, D.B. (1988) Membrane and matrix localization of proteinases: A common theme in tumor cell invasion and angiogenesis. Biochem. Biophys. Acta 948: 67–85.
Zucker, S., Moll, V.M., Lysik, R.M., DiMassiuro E.T., Stetler-Stevenson, W.G., Liotta, L.A., Schwedes, J.W. (1990) Extraction of type IV collagenase/gelatinase from plasma membranes of human cancer cells. Int. J. Cancer 46:1137–1142.
Ossowski, L., Reich, E. (1983) Antibodies to plasminogen activator inhibit human tumor metastasis. Cell 35:611–619.
Mignatti, P., Robbins, E., Rifkin, D.B. (1986) Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascade. Cell 47:487–498.
Weiss, S.J. (1989) Tissue destruction by neutrophils. N. Engl. J. Med. 320:365–376.
Okada, Y., Watanake, S., Nakamishi, I., Kishi, J., Hayakawa, T., Watork, W., Travis, J., Nagase, H. (1988) Inactivation of tissue inhibitor of metalloproteinase by neutrophil elastase and other serine proteinases. FEBS Lett. 229:157–160.
Michaelis, J., Vissers, M.C.M., Winterbourne, C.C. (1990) Human neutrophil collagenase cleaves α1 antitrypsin. Biochem. J. 270:809–814.
Gross, J., Lapiere, C.M. (1962) Collagenolytic activity in amphibian tissues: A tissue culture assay. Proc. Natl. Acad. Sci. U.S.A. 48:1014–1022.
Goldberg, G.I., Wilhelm, S.M., Kronberger, A., Bauer, E.A., Grant, G.A., Eisen, A.Z. (1986) Human fibroblast collagenase: Complete primary structure and homology to an oncogene transformation-induced rat protein. J. Biol. Chem. 261:6600–6605.
Matrisian, L.M., Leroy, P., Ruhlmann, C., Gesnel, M.-C., Breathnach, R. (1986) Isolation of the oncogene and epidermal growth factor-induced transin gene: Complex control in rat flbroblasts. Mol. Cell. Biol. 6:1679–1686.
Whitham, S.E., Murphy, G., Angel, P., Rahmsdorf, H.J., Smith, B.J., Lyons, A., Harris, T.J.R., Reynolds, J.J., Herrlich, P., Docherty, A.J.P. (1986) Comparison of human stromelysin and collagenase by cloning and sequence analysis. Biochem. J. 240:913–916.
Collier, I.E., Wilhelm, S.M., Eisen, A.Z., Marmer, B.L., Grant, G.A., Seltzer J.L., Kronberger, A., He, C., Bauer, E.A., Goldberg, G.I. (1988) H-ras oncogene transformed human bronchial epithelial cells (TBE-1) secrete a single metalloproteinase capable of degrading basement membrane collagen. J. Biol. Chem. 263:6579–6587.
Wilhelm, S.M., Collier, I.E., Marmer, B.L., Eisen, A.Z., Grant, G.A., Goldberg, G.I. (1989) SV40-transformed human lung fibroblasts secrete a 92-kDa type-IV collagenase which is identical to that secreted by normal human macrophages. J. Biol. Chem. 264:17213–17221.
Quantin, B., Murphy, G., Breathnach, R. (1989) Pump-1 cDNA codes for a protein with characteristics similar to those of classical collagenase family members. Biochemistry 28:5327–5334.
Muller, D., Quantin, B., Gesnel, M.-C., Millon-Collard, R., Abecassis, J., Breathnach, R. (1988) The collagenase gene family in humans consists of at least four members. Biochem. J. 253:187–192.
Hasty, K.A., Pourmotabbed, T.F., Goldberg, G.I., Thompson, J.P., Spinella, D.G., Stevens, R.M., Mainardi, C.M. (1990) Human neutrophil collagenase. A distinct gene product with homology to other matrix metalloproteinases.. J. Biol. Chem. 265:11421–11424.
Basset, P., Bellocq, J.P., Wolf, C., Stoll, I., Hutin, P., Limacher, J.M., Podhajcer, O.L., Chenard, M.P., Rio, M.C., Chambon, P. (1990) A novel metalloproteinase gene specifically expressed in stromai cells of breast carcinomas. Nature 348:699–704.
Angel, P., Baumann, L, Stein, B., Delius, H, Rahmsdorf, H.J., Herrlich, P. (1987) 12-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5′-flanking region. Mol. Cell. Biol. 7:2256–2266.
Huhlala, P., Chow, L.T., Tryggvason, K. (1990) Structure of the human type IV collagenase gene. J. Biol. Chem. 265:11077–11082.
Kerr, L.D., Miller, D.B., Matrisian, L.M. (1990) TGF-β1 inhibition of transin/stromelysin gene expression is mediated through a fos binding sequence. Cell 61:267–278.
Ho, C., Wilhelm, S.M., Pentland, A.P., Marmer, B.L., Grant, G.A., Eisen, A.Z., Goldberg, G.I. (1989) Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc. Natl. Acad. Sci. U.S.A. 86:2632–2636.
Stetler-Stevenson, W.G., Krutzsch, H.C., Wacher, M.P., Margulies, I.M.K., Liotta, L.A. (1989) The activation of human type IV collagenase proenzyme. Sequence identification of the major conversion product following organomercurial activation. J. Biol. Chem. 264:1353–1356.
Brown, P.D., Levy, A.T., Margulies, I.M.K., Liotta, L.A., Stetler-Stevenson, W.G. (1990) Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res 50:6184–6191.
Vallee, B.L., Auld, D.S. (1990) Zinc coordination, function and structure of zinc enzymes and other proteins. Biochemistry 29:5647–5659.
Van Wart, H.E., Birkedal-Hansen, H. (1990) The cysteine switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc. Natl. Acad. Sci. U.S.A. 87:5578–5582.
Stetler-Stevenson, W.G., Talano, J.-A., Gallager, M.E., Krutzsch, H.C., Liotta, L.A. (1991) Inhibition of human type IV collagenase by a highly conserved peptide sequence derived from its prosegment. Am. J. Med. Sci. 302:163–170.
Liotta, L.A., Abe, S., Robey, P.G., Martin, G.R. (1979) Preferential digestion of basement membrane collagen by an enzyme derived from a metastatic murine tumor. Proc. Natl. Acad. Sci. U.S.A. 76:2268–2272.
Liotta, L.A., Tryggvason, K., Garbisa, S., Hart, I., Foltz, C.M., Schaffte, S. (1980) Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284:67–68.
Fessier, L., Duncan, K., Tryggvason, K. (1984) Identification of the procollagen IV cleavage products produced by a specific tumor collagenase. J. Biol. Chem. 259:9783–9789.
Moll, U.M., Youngleib, G.L., Rosinski, K.B., Quigley, J.P. (1990) Tumor promoterstimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: Isolation and characterization of the enzyme from HT-1080 tumour cells. Cancer Res. 50:6162–6170.
Senior, R.M., Griffin, G.L., Flizar, C.J., Shapiro, S.D., Goldberg, G.I., Welgus, H.G. (1991) Human 92-and 72-kilodalton type IV collagenases are elastases. J. Biol. Chem. 266:7870–7875.
Welgus, H.G., Flizar, C.J., Seltzer, J.L., Schmid, T.M., Jeffery, J.J. (1990) Differential susceptibility of type X collagen to cleavage by two mammalian interstitial collagenases and 72-kDa type IV collagenase. J. Biol. Chem. 265:13521–13527.
Stetler-Stevenson, W.G., Krutzsch, H.C., Liotta, L.A. (1989) Tissue inhibitor of metalloproteinase (TIMP-2): A new member of the metalloproteinase inhibitor family. J. Biol. Chem. 264:17374–17378.
Goldberg, G.I., Marmer, B.L., Grant, G.A., Eisen, A.Z., Wilhelm, S., He, C. (1989) Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc. Natl. Acad. Sci. U.S.A. 86:8207–8211.
Declerck, Y.A., Yean, T.D., Ratzkin, B.J., Lu, H.S., Langley, K.E. (1989) Purification and characterization of two related but distinct metalloproteinase inhibitors secreted by bovine aortic endothelial cells. J. Biol. Chem. 264:17445–17453.
Stetler-Stevenson, W.G., Brown, P.D., Onisto, M., Levy, A., Liotta, L.A. (1990) Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J. Biol. Chem. 265:13933–13938.
Howard, E.W., Bullen, E.C., Banda, M.J. (1991) Preferential inhibition of 72 kDa and 92 kDa gelatinases by TIMP-2. J. Biol. Chem., in press.
Brinckerhoff, C.E., Plucinska, I.M., Sheldon, L.A., O’Connor, G.T. (1986) Half-life of synovial cell collagenase mRNA is modulated by phorbol myristate acetate but not by all-trans-retinoic acid or dexamethasone. Biochemistry 25:6378–6384.
Kreig, P., Finch, J., Furstenberger, G., Melber, K., Matrisian, L.M., Bowden, G.T. (1988) Tumor promoters induce a transient expression of tumor-associated genes in both basal and differentiated cells of the mouse epidermis. Carcinogenesis 9:95–100.
Edwards, D.R., Murphy, G., Reynolds, J.J., Whitham, S.E., Docherty, A.J.P., Angel, P., Health, J.K. (1987) Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 6:1899–1904.
Overall, C.M., Wrana, J.L., Sodek, J. (1989) Independent regulation of collagenase, 72-kDa progelatinase, and metalloproteinase inhibitor expression in human fibroblasts by transforming growth factor-β. J. Biol. Chem. 264:1860–1869.
MacNaul, K.L., Chartrain, N., Lark, M., Tocci, M.J., Hutchinson, N.I. (1990) Discoordinate expression of stromelysin, collagenase and tissue inhibitor of metalloproteinase-1 in rheumatoid human synovial fibroblasts. J. Biol. Chem. 265:17238–17245.
Suziki, K., Enghild, J.J., Morodarni, T., Salvesen, G., Nagase, H. (1990) Mechanism of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin). Biochemistry 29:10261–10270.
Briurckerhoff, C.E., Suzuki, K., Mitchell, T.I., Dram, F., Coon, C.I., Palmiter, R.D., Nagase, H. (1990) Rabbit procollagenase synthesized and secreted by a high-yield mammalian expression vector requires stromelysin (matrix metalloproteinase-3) for maximal activation. J. Biol. Chem. 265:22266–22269.
Overall, C.M., Sodek, J. (1990) Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. J. Biol. Chem. 265:21141–21151.
Brown, P.D., Kleiner, D., Unsworth, E., Stetler-Stevenson, W.G. (1992) Cellular activation mechanism of the 72 kDa type IV collagenase TIMP-2 complex. Kidney Int. (in press).
Weinberg, W.C, Brown, P.D., Stetler-Stevenson, W.G., Yuspa, S.H. (1990) Growth factors specifically alter hair follicle cell proliferation and collagenolytic activity alone or in combination. Differentiation 45:163–178.
Apodaca, G., Rutka, J.T., Bouhana, K., Berens, M.E., Giblin, J.R., Rosenblum, M.L., McKerrow, J.H., Banda, M.J. (1990) Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells. Cancer Res. 50:2322–2329.
Rifas, L., Halstead, L.R., Peck, W.A., Avioli, L.V., Welgus, H.G. (1990) Human osteoblasts in vitro secrete tissue inhibitor of metalloproteinases and gelatinase but not interstitial collagenase as major cellular products. J. Clin. Invest. 84:686–694.
Murphy, G., Cawston, T., Reynolds, J. (1981) An inhibitor of collagenase from human amniotic fluid. Purification, characterization and action on metalloproteinases. Biochem. J. 195:167–170.
Stricklin, G.P., Welgus, H.G. (1983) Human skin fibroblast collagenase inhibitor: Purification and biochemical characterization. J. Biol. Chem. 258:12252–12258.
Carmichael, D.F., Sommer, A., Thomson, R., Anderson, D.C., Smith, C.G., Welgus, H.G., Stricklin, G.P. (1986) Primary structure and cDNA cloning of human fibroblast collagenase inhibitor. Proc. Natl. Acad. Sci. U.S.A. 83:2407–2411.
Spurr, N.K., Goodfellow, P.N., Docherty, A.J.P. (1987) Chromosomal assignment of the gene encoding the human tissue inhibitor of metalloproteinases to Xp11.1-Xp11.4. Ann. Human Genet. 51:189–194.
Docherty, A.J.P., Lyons, A., Smith, B.J., Wright, E.M., Stephens, P.E., Harris, T.J.R., Murphy, G., Reynolds, J.J. (1985) Sequence of tissue inhibitor of metalloproteinases and its identity to erythroid potentiating activity. Nature 318:66–69.
Williamson, R.A., Marston, F.A.O., Angal, S., Koklitis, P., Panico, M., Morris, H.R., Came, A.F., Smith, B.J., Harris, T.J.R., Freedman, R.B. (1990) Disulphide bond assignment in human tissue inhibitor of metalloproteinases (TIMP). Biochem. J. 268:267–274.
Boone, T.C., Johnson, M.J., DeClerck, Y.A., Langley, K.E. (1990) cDNA cloning and expression of a metalloproteinase inhibitor related to tissue inhibitor of metalloproteinase. Proc. Natl. Acad. Sci. U.S.A. 82:2800–2804.
Brown, P.D., Gallagher, M.E., Wacher, M.P., Liotta, L.A., Stetler-Stevenson, W.G. (1992) Co-ordinate expression of TIMP-2 and 72-kDa type IV collagenase in human cell lines. Submitted.
Ponton, A., Coulombe, B., Skup, D. (1991) Decreased expression of tissue inhibitor of metalloproteinases in metastatic tumor cell leading to increased levels of collagenolytic activity. Cancer Res. 51:2138–2143.
Kao, R.T., Stern, R. (1986) Collagenases in human breast carcinoma cell lines. Cancer Res. 46:1349–1354.
Zeydel, M., Nakagawa, S., Biempica, L., Takahashi, S. (1986) Collagenase and elastase production by mouse mammary adenocarcinoma primary cultures and cloned cells. Cancer Res. 46:6438–6445.
Barsky, S.H., Togo, S., Garbisa, S., Liotta, L.A. (1983) Type IV collagenase immunoreactivity in invasive breast carcinoma. Lancet 8319:296–297.
Monteagudo, C., Merino, M.J., San-Juan, J., Liotta, L.A., Stetler-Stevenson, W.G. (1990) Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue. Am. J. Pathol. 136:585–592.
D’Errico, A., Garbisa, S., Liotta, L.A., Castronovo, V., Stetler-Stevenson, W.G., Grigioni, W.F. (1991) Augmentation of type IV collagenase, laminin receptor, and Ki62 proliferation antigen associated with human colon, gastric and breast carcinoma progression. Mod. Pathol. 4:239–246.
Daidone, M.G., Silvestrini, R., D’Errico, A., DiFronzo, G., Benini, E., Maricini, A.M., Garbisa, S., Liotta, L.A., Grigioni, W.F. (1991) Laminin receptors, collagenase IV and prognosis in node-negative breast cancers. Int. J. Cancer, in press.
Ogilvie, D.J., Hailey, J.A., Juacaba, S.F., Lee, E.C., Tarin, D. (1985) Collagenase secretion by human breast neoplasms: A clinicopathologic investigation. J. Natl. Cancer Inst. 74:19–27.
Nakajima, M., Welch, D.R., Belloni, P.N., Nicolson, G.L. (1987) Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic protentials. Cancer Res. 47:4869–4876.
Liotta, L.A., Tryggvason, K., Garbisa, S., Hart, I., Foltz, C.M., Schaffie, S. (1980) Metastatic potential correlates with enzymic degradation of basement membrane collagen. Nature 248:67–68.
Schultz, R.M., Silberman, S., Persky, B., Bajkowski, A.S., Carmichael, D.F. (1988) Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells. Cancer Res. 48:5539–5545.
Albini, A., Melchiori, A, Santi, L., Liotta, L.A., Brown, P.D., Stetler-Stevenson, W.G. (1991) Tumor cell invasion inhibited by TIMP-2., J. Natl. Cancer Inst. 83:775–779.
Kane, S.E., Gottesman, M.M. (1990) The role of cathepsin L in malignant transformation. Semin. Cancer Biol. 1:127–136.
Sloane, B.F. (1990) Cathepsin B and csytatins: Evidence for a role in cancer progression. Semin. Cancer Biol. 1:137–152.
Rochefort, H., Capony, F., Garcia, M. (1990) Cathepsin D: A protease involved in breast cancer metastasis. Cancer Metast. Rev. 9:321–331.
Takigawa, M., Nishida, Y., Suzuki, F., Kishi, J., Yamashita, K., Hayakawa, T. (1990) Induction of angiogenesis in chic yolk-sac membrane by polyamines and its inhibition by tissue inhibitors of metalloproteinases (TIMP and TIMP-2). Biochem. Biophys. Res. Commun. 171:1264–1271.
Folkman, J. (1990) What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst. 82:4–6.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media New York
About this chapter
Cite this chapter
Stetler-Stevenson, W.G., Liotta, L.A., Brown, P.D. (1991). Role of type IV collagenases in human breast cancer. In: Dickson, R.B., Lippman, M.E. (eds) Genes, Oncogenes, and Hormones. Cancer Treatment and Research, vol 61. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3500-3_2
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3500-3_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6552-5
Online ISBN: 978-1-4615-3500-3
eBook Packages: Springer Book Archive